Preparation and Characterization of Osthole Liposomes

doi:10.3969/j.issn.2095-1396.2017.05.004

Abstract

Abstract:

Objective：To research the preparation methods，prescriptions and preparation properties of osthole loaded liposomes，and the lyophilized liposomes was prepared to improve the stability of the preparation. Methods：Encapsulation efficiency was taken as index to screen the preparation of liposomes；the formulation was optimized by single factor prescription analysis and orthogonal test. The encapsulation efficiency，particle size and potential of the osthole
liposomes were measured，and the morphology under transmission electron microscope was observed；mannitol was selected as a freeze-drying agent，we explored the effect of its addition on the encapsulation efficiency of lyophilized liposomes. Results：The liposomes were prepared by ethanol injection method. The optimal formulations were EPC 4 mg·mL-1，CHOL 5 mg，Ost 2 mg，and at 50℃ reactive temperature. The encapsulation efficiency of liposome was （83.09±0.56） %，the particle size was（ 101.9±2.7） nm，and the potential was（ -15.3±2.3） mV. When the amount of mannitol was 8%，the lyophilized liposomes had better morphology and less leakage.Conclusion：Liposome which has high entrapment efficiency and well-distributed particle size was prepared by ethanol injection. After preparation of lyophilized liposomes，the stability of liposomes was improved.

Key words: osthole, liposome, ethanol injection, lyophilized liposomes

CLC Number:

R944.1

ZHAO Kai-yan1，ZHANG Dan-shen1，SU Xiao-mei1，ZHANG Hai-wei2，HOU Wen-shu2. Preparation and Characterization of Osthole Liposomes[J]. Acta Neuropharmacologica, DOI: 10.3969/j.issn.2095-1396.2017.05.004.

References

[1] Hua Kuo-feng, Yang Shun-min, Kao Tzu-Yang, et al. Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway[J]. PLoS One, 2013, 8(10): e77794

[2] Liu Ya-wei Liu, Yung-Tsung Chiu, Fu Shu-ling, et al. Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation[J]. Biomed Sci, 2015, 22(1): 63.

[3] Xu Xiao-man, Zhang Yi, Qu Dan, et al. Osthole induces G2/M arrest and apoptosis in lung modulating PI3K/Akt pathway[J]. Exp Clin Cancer Res, 2011, 30(1): 33.

[4] Luszczki Jarogniew J, AndresMach Marta, Cisowski Wojciech, et al. Osthole suppresses seizures in the mouse maximal electroshock seizure model[J]. Eur J Pharmacol, 2009, 607(1-3): 107-109.

[5] Leung Y M, Kuo Y H, Chao C C, et al. Osthol is a use dependent blocker of voltage-gated Na⁺ channels in mouseneuroblastoma N2A cells[J]. Planta Medica, 2010, 76(1): 34-40.

[6] Wu Sheng-nan, Lo Yuk-Kang Chen, Chien-Chich, et al. Inhibitory effect of the plant-extract Osthole on L-type calcium current in NG108-15 neuronal cells[J]. Biochemical Pharmacology, 2002, 63(2): 199-206.

[7] Liu Wen-bo, Zhou Jun, Qu Yan, et al. Neuroprotective effect of Osthole on MPP+-induced cytotoxicity in PC12 cells via inhibition of mitochondrial dysfunction and ROS production[J]. Neurochemistry International, 2010, 57(3): 206-215.

[8] 陆姗姗, 王冬月, 顾薇, 等. 转铁蛋白修饰香豆素-6脂质体的制备与评价[J]. 中国新药杂志, 2015, 24(13): 1537-1540

[9] 赖滢滢, 王岩, 张英丰. 星点设计-效应面法进行蛇床子素脂质体处方优化的研究[J]. 中国新药杂志, 2015, 24(06): 708-712+720.

[10] Catherine Charcosset, Audrey Juban, Jean-Pierre Valour, et al. Preparation of liposomes at large scale using the ethanol inj ection method: Effect of scale-up and inj ection devices[J]. Chemical Engineering Research and Design, 2015, 94(2): 508-515.

[11] 张成龙, 张季, 康聪, 等.蛇床子素脂质体的处方优化及其体外释放度[J]. 中国医药工业杂志, 2016, 47(06): 728-731.

[12] 赖滢滢. 蛇床子素脂质体凝胶的制备与评价[D]. 广州：广东药科大学, 2016.

[13] 赵凯燕, 张丹参. 脂质体包封率的研究进展[J]. 神经药理学报, 2016, 6(06): 23-30.

[14] Liu Yan, Luo Xiao, Xu Xiao-chao, et al. Preparation characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes[J]. Int J Pharm, 2017, 517 (1-2): 1-7.

[15] 唐文雅, 宋艳志, 邓意辉. 脂质体冻干保护剂的种类及其作用机制研究进展[J]. 沈阳药科大学学报, 2012, 29(07): 560-569.